Diabetes mellitus and COVID-19 in Moscow: status 2020

• Nikolay A. Demidov
• Anna V. Andreeva
• Mikhail B. Antsiferov

Abstract

Against the backdrop of the COVID-19 pandemic, there is an increase in the number of deaths among the population of all countries. At the same time, separate groups of patients are distinguished, the mortality rate in which significantly exceeds the average. Patients with diabetes mellitus certainly belong to one of these groups. Numerous studies in various countries have demonstrated a higher risk of COVID-19 infection for people with diabetes, as well as a more severe course of the disease and a higher mortality rate. The Moscow segment of the Federal Register of Diabetic Patients as of 01.01.2021 contains information on 7335 diabetic patients who fell ill with COVID-19 during 2020, of which 818 people died. This article presents an analysis of the indicators of diabetes patients with COVID-19, taking into account the outcomes of the disease.

Keywords:COVID-19, diabetes mellitus, Federal Diabetes Registry

REFERENCES

1. URL: https://COVID-19.who.int/

2. Viveiros A., Rasmuson J., Vu J., Mulvagh S.L., Yip C.Y.Y., Norris C.M., et al. Sex differences in COVID-19: candidate pathways, genetics of ACE 2, and sex hormones. Am J Physiol Heart Circ Physiol. 2021; 320 (1): H296-304. DOI: https://doi.org/10.1152/ajpheart.00755.2020 PMID: 33275517.

3. Clerkin K.J., Fried J.A., Raikhelkar J., Sayer G., Griffin J.M., Ma-soumi A., et al. Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation. 2020; 141: 1648-55. DOI: https://doi.org/10.1161/CIRCULATIONAHA.120.046941

4. Zhu L., She Z.G., Cheng X., Qin J.J., Zhang X.J., Cai J., et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020; 31 (6): 1068-77.e3. DOI: https://doi.org/10.1016/j.cmet.2020.04.021 PMID: 32369736; PMCID: PMC 7252168.

5. Roncon L., Zuin M., Rigatelli G., Zuliani G. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. J Clin Virol. 2020; 127: 104354.

6. Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W., et al.; the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020; 323 (20): 2052-9. DOI: https://doi.org/10.1001/jama.2020.6775 Erratum in: JAMA. 2020; 323 (20): 2098. PMID: 32320003; PMCID: PMC 7177629.

7. Jeong I.K., Yoon K.H., Lee M.K. Diabetes and COVID-19: global and regional perspectives. Diabetes Res Clin Pract. 2020; 166: 108303. PMCID: PMC 7332438 PMID: 32623038

8. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497-506.

9. Suleyman G., Fadel R.A., Malette K.M., et al Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan Detroit. JAMA Netw Open. 2020; 3: e2012270.

10. Guo W., Li M., Dong Y., Zhou H., Zhang Z., Tian C. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020; Mar 31: e3319. DOI: https://doi.org/10.1002/dmrr.3319

11. Yan Y., Yang Y., Wang F., Ren H., Zhang S., Shi X. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ Open Diabetes Res Care. 2020; 8. DOI: https://doi.org/10.1136/bmjdrc-2020-001343

12. Huang I., Lim M.A., Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia -a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020; 14 (4): 395-403. DOI: https://doi.org/10.1016/j.dsx.2020.04.018 PMID: 32334395; PMCID: PMC 7162793.

13. Azevedo R.B., Botelho B.G., Hollanda J.V.G., Ferreira L.V.L., Junqueira de Andrade L.Z., Oei S.S.M.L., et al. COVID-19 and the cardiovascular system: a comprehensive review. J Hum Hypertens. 2021; 35 (1): 4-11. DOI: https://doi.org/10.1038/s41371-020-0387-4 PMID: 32719447; PMCID: PMC 7384729.

14. Sardu C., D’Onofrio N., Balestrieri M.L., Barbieri M., Rizzo M.R., Messina V., et al. Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control? Diabetes Care. 2020; 43 (7): 1408-15. DOI: https://doi.org/10.2337/dc20-0723 PMID: 32430456; PMCID: PMC 7305003.

15. Bode B., Garrett V., Messler J., et al Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol. 2020; 14: 813-21.

16. Antsiferov M.B., Demidov N.A., Kalashnikova M.F., Dukhareva O.B., Vikulova O.K., Shestakova M.B. The dynamics of the main epidemiological indicators among living in Moscow patients with diabetes mellitus (2013-2018). Sakharniy diabet [Diabetes Mellitus]. 2020; 23 (2): 11324. (in Russian)

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)